1. Home
  2. IT vs HALO Comparison

IT vs HALO Comparison

Compare IT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$150.35

Market Cap

10.5B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$66.47

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IT
HALO
Founded
1979
1998
Country
United States
United States
Employees
40
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
8.8B
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
IT
HALO
Price
$150.35
$66.47
Analyst Decision
Hold
Buy
Analyst Count
9
11
Target Price
$189.25
$78.64
AVG Volume (30 Days)
1.3M
1.2M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.18
2.56
Revenue
$2,021,441,000.00
$151,862,000.00
Revenue This Year
$3.52
$28.24
Revenue Next Year
$5.08
$12.56
P/E Ratio
$47.26
$25.74
Revenue Growth
13.30
N/A
52 Week Low
$139.18
$47.50
52 Week High
$451.73
$82.22

Technical Indicators

Market Signals
Indicator
IT
HALO
Relative Strength Index (RSI) 46.77 51.34
Support Level $142.76 $63.85
Resistance Level $162.87 $68.00
Average True Range (ATR) 5.60 1.95
MACD 0.18 -0.05
Stochastic Oscillator 42.14 46.22

Price Performance

Historical Comparison
IT
HALO

About IT Gartner Inc.

Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: